SThree plc (LON:STEM – Get Free Report) announced a dividend on Tuesday, July 23rd, Upcoming.Co.Uk reports. Shareholders of record on Thursday, November 7th will be given a dividend of GBX 5.10 ($0.07) per share on Friday, December 6th. This represents a yield of 1.22%. The ex-dividend date is Thursday, November 7th. The official announcement can be accessed at this link.
SThree Price Performance
Shares of LON:STEM opened at GBX 355.50 ($4.63) on Wednesday. The company has a market cap of £472.46 million, a PE ratio of 848.81, a P/E/G ratio of 0.75 and a beta of 0.98. SThree has a fifty-two week low of GBX 326 ($4.24) and a fifty-two week high of GBX 457.50 ($5.96). The firm has a 50-day simple moving average of GBX 381.45 and a 200 day simple moving average of GBX 407.21. The company has a quick ratio of 1.69, a current ratio of 1.89 and a debt-to-equity ratio of 11.91.
Analysts Set New Price Targets
Separately, Jefferies Financial Group dropped their price target on SThree from GBX 430 ($5.60) to GBX 420 ($5.47) and set a “hold” rating on the stock in a research report on Tuesday, July 16th.
Insider Buying and Selling at SThree
In related news, insider Timo Lehne acquired 85,028 shares of the business’s stock in a transaction that occurred on Wednesday, September 25th. The shares were acquired at an average cost of GBX 375 ($4.88) per share, for a total transaction of £318,855 ($415,067.69). Over the last 90 days, insiders have bought 85,107 shares of company stock worth $31,915,273. 6.23% of the stock is owned by company insiders.
SThree Company Profile
SThree plc provides specialist recruitment services in the sciences, technology, engineering, and mathematics markets in the United Kingdom, Austria, Germany, Switzerland, Netherlands, Spain, Belgium, France, the United States, Dubai, Japan. The company offers recruitment services for permanent and contract roles, as well as support services.
Featured Articles
- Five stocks we like better than SThree
- Short Selling: How to Short a Stock
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- Differences Between Momentum Investing and Long Term Investing
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
- Canadian Penny Stocks: Can They Make You Rich?
- Astera Labs’ Big Stock Jump: Can the Growth Be Sustained?
Receive News & Ratings for SThree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SThree and related companies with MarketBeat.com's FREE daily email newsletter.